Every SEC Form 3/4/5 on record for this filer (CIK 1218629) — 1 issuer, 104 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO · Director | 2015-09-03 → 2026-01-05 | 23 | −$320M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| REGN | 2024-06-12 | Sell | 1,000 | $1,025.27 | $1M | — |
| REGN | 2024-06-12 | Sell | 14,879 | $1,015.30 | $15M | 40,255 |
| REGN | 2024-06-12 | Sell | 270 | $1,016.62 | $274,487 | 39,985 |
| REGN | 2024-06-11 | Sell | 1,743 | $1,016.04 | $2M | 55,134 |
| REGN | 2024-06-11 | Sell | 7,321 | $1,015.28 | $7M | 56,877 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.